Disease Info Card

Malignant Peripheral Nerve Sheath Tumor

Information about Malignant Peripheral Nerve Sheath Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Malignant Peripheral Nerve Sheath Tumor

Most recent studies have shown that Malignant Peripheral Nerve Sheath Tumor shares some biological mechanisms with fibrosarcoma, histiocytoma, histiocytoma-benign-fibrous, leiomyosarcoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nerve-sheath-tumors, neurilemmoma, neurofibroma, neurofibromatoses, neurofibromatosis-1, peripheral-nerve-sheath-neoplasm, peripheral-nervous-system-neoplasms, rhabdomyosarcoma, sarcoma, soft-tissue-neoplasms, synovial-sarcoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Malignant Peripheral Nerve Sheath Tumor, and have been seen in publications frequently: Angiogenesis, Autophagy, Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Interphase, Localization, Metaphase, Methylation, Mitosis, Muscle Atrophy, Oncogenesis, Pathogenesis, Pigmentation, Regeneration, Reverse Transcription

Quite a number of genes have been found to play important roles in Malignant Peripheral Nerve Sheath Tumor, such as CD34, CDKN2A, DES, EGFR, ENO2, ERBB2, GFAP, MUC1, NF1, NF2, S100A1, S100B, SS18L1, TP53, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.